Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,103 | -3,003 | -1,670 | -5,751 | -4,120 |
| Depreciation Amortization | 456 | 295 | 124 | 510 | 364 |
| Accounts payable and accrued liabilities | -488 | -369 | -59 | 499 | 385 |
| Other Working Capital | 82 | 127 | 295 | 1,519 | 1,259 |
| Other Operating Activity | 1,460 | 1,191 | 504 | 551 | 204 |
| Operating Cash Flow | $-2,594 | $-1,760 | $-807 | $-2,672 | $-1,909 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | 1 | 1 | -11 | N/A |
| Investing Cash Flow | $-1 | $1 | $1 | $-11 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 670 | 670 | 140 | 1,454 | 979 |
| Debt Repayment | -53 | -53 | -25 | -6 | -4 |
| Common Stock Issued | 2,175 | 1,025 | 625 | 1,411 | 905 |
| Other Financing Activity | -25 | -25 | -25 | 25 | 29 |
| Financing Cash Flow | $2,767 | $1,617 | $715 | $2,884 | $1,909 |
| Beginning Cash Position | 201 | 201 | 201 | 0 | 0 |
| End Cash Position | 374 | 59 | 110 | 201 | 1 |
| Net Cash Flow | $173 | $-142 | $-91 | $201 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,594 | -1,760 | -807 | -2,672 | -1,909 |
| Capital Expenditure | -2 | N/A | N/A | -11 | N/A |
| Free Cash Flow | -2,595 | -1,760 | -807 | -2,684 | -1,909 |